Literature DB >> 22931972

Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.

Yue-Yun Lai1, Xiao-Jun Huang, Zhen Cai, Xiang-Shan Cao, Fang-Ping Chen, Xie-Qun Chen, Bao-An Chen, Mei-Yun Fang, Jia-Fu Feng, Wei-Ling Fu, Hai-Ying Guo, Ming Hou, Jian Hou, Yu Hu, Xiao-Tong Hu, Xiao-Mei Hu, Li-Qiang Huang, Jie Jin, Jian-Yong Li, Juan Li, Wei Li, Ying-Min Liang, Ting Liu, Qi-Fa Liu, Yan-Hui Liu, Ping Mao, Jian Ouyang, Lu-Gui Qiu, Lin Qiu, Chun-Kui Shao, Bin Shi, Yong-Ping Song, Zi-Min Sun, Qi-Shan Wang, Chun Wang, Jian-Ming Wang, Yun-Shan Wang, Zhao Wang, Jian-Bo Wu, Yin-Xia Wu, Rui-Xiang Xia, Yong-Quan Xue, Bao-Zhen Yang, Guang Yang, Zheng-Lin Yang, Li Yu, Zhong Yuan, Sheng Zhang, Yin Zhang, Hong-Guo Zhao, Li Zhao, Dao-Bin Zhou, Shan-Hua Zou, Yun-Feng Zhu.   

Abstract

BACKGROUND: Chromosomal abnormalities have been shown to play an important prognostic role in multiple myeloma (MM). Interphase fluorescence in situ hybridization (i-FISH) has been much more effective to identify cytogenetic aberrations in MM than conventional cytogenetic technique (CC). To clearly determine the cytogenetic features of Chinese MM patients and identify their prognostic implications, we designed a multicenter study based on i-FISH including 672 patients from 52 hospitals in China.
METHODS: All 672 patients were systematically screened for the following genomic aberrations: del(13q), IgH rearrangement, del(p53) and 1q21 amplifications.
RESULTS: The analysis showed that the chromosomal changes were detected in 22.1% patients by CC and in 82.3% patients by i-FISH. The most common abnormalities by CC were chromosome 1 aberrations (48.4%), -13/13q- (37.6%), hyperdiploidy (36.6%), hypodiploidy (30.1%) and IgH rearrangements (23.7%). The most frequent abnormalities by FISH was del(13q), which was found in 60.4% patients, whereas IgH rearrangement, 1q21 amplification and p53 deletions were detected in 57.6%, 49.0% and 34.7% cases, respectively. By statistical analysis, -13/13q- by CC was associated with low level of platelet (P = 0.015), hyperdiploidy was associated with low level of serum albumin (P = 0.028), and IgH rearrangement by FISH was associated with high level of β2 microglobulin (P = 0.019). Moreover, 1q21 amplification and del(p53) by FISH conferred a high incidence of progressive disease (PD) after initial therapy. Metaphase detection of IgH rearrangements and chromosome 1 aberrations concurrently was associated with a short progression free survival (PFS) (P = 0.036). No significant prognostic implications of other cytogenetic abnormalities were found associated with overall survival and PFS.
CONCLUSIONS: Chinese MM patients had similar cytogenetic abnormalities compared with the previous reported studies. However, the prognostic significance of FISH aberrations were not clearly determined and further study is required.

Entities:  

Mesh:

Year:  2012        PMID: 22931972

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.

Authors:  Cigdem Aydin; Turgay Ulas; Ceren Hangul; Orhan Kemal Yucel; Utku Iltar; Ozan Salim; Deniz Ekinci; Sibel Berker Karauzum
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-25       Impact factor: 0.900

2.  MMSA-1 expression pattern in multiple myeloma and its clinical significance.

Authors:  Shan Meng; Chenyang Lu; Wanggang Zhang; Wenjun Shen; Yongchang Wei; Dan Su; Fuling Zhou
Journal:  Clin Exp Med       Date:  2015-10-22       Impact factor: 3.984

3.  Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.

Authors:  Edmond S K Ma; Candy L N Wang; Anthony T C Wong; Gigi Choy; Tsun Leung Chan
Journal:  Mol Cytogenet       Date:  2016-08-16       Impact factor: 2.009

4.  [Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma].

Authors:  X L Liu; Y P Yang; J Bai; T T Yue; P Y Yang; Y Zhang; H Q Fan; W Li; F Y Jin
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-11-14

5.  [Epidemiological analysis of cytogenetic abnormalities in patients with newly-diagnosed multiple myeloma: a multi-center retrospective study].

Authors:  R F Yuan; Y J Dong; C R Li; W R Huang; L M Zhang; Q Zhu; L Xu; Y J Xu; Q Xu; G X Gao; F Y Jin
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

6.  1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.

Authors:  Xiaozhe Li; Wenming Chen; Yin Wu; Jianyong Li; Lijuan Chen; Baijun Fang; Ying Feng; Junru Liu; Meilan Chen; Jingli Gu; Beihui Huang; Juan Li
Journal:  Oncologist       Date:  2019-08-27

7.  A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea.

Authors:  Shuhua Li; Hyeon-Ho Lim; Kwang-Sook Woo; Sung-Hyun Kim; Jin-Yeong Han
Journal:  Blood Res       Date:  2016-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.